Back
Avenue Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
ATXI
Avenue Therapeutics, Inc.
Last Price:
$0.35
Seasonality Move:
-18.36%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATXI is experiencing slight buying pressure.
Avenue Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.31 | Buy |
| 20-day SMA: | 0.27 | Buy |
| 50-day SMA: | 0.24 | Buy |
| 200-day SMA: | 0.52 | Sell |
| 8-day EMA: | 0.3 | Buy |
| 20-day EMA: | 0.23 | Buy |
| 50-day EMA: | 0.13 | Buy |
| 200-day EMA: | 0.04 | Buy |
Avenue Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 62.2 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.21 - 0.31) | Buy |
| Bollinger Bands (100): | (0.23 - 0.73) | Sell |
Avenue Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avenue Therapeutics, Inc. Stock
Is Avenue Therapeutics, Inc. Stock a Buy?
-
Avenue Therapeutics, Inc. share price is 0.35 while ATXI 8-day simple moving average is 0.31, which is a Buy signal.
-
The stock price of ATXI is 0.35 while Avenue Therapeutics, Inc. 20-day SMA is 0.27, which makes it a Buy.
-
Avenue Therapeutics, Inc. 50-day simple moving average is 0.24 while ATXI share price is 0.35, making it a Buy technically.
-
ATXI stock price is 0.35 and Avenue Therapeutics, Inc. 200-day simple moving average is 0.52, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
38
Avenue Therapeutics, Inc. (ATXI)
is a Sell
Is Avenue Therapeutics, Inc. a Buy or a Sell?
-
Avenue Therapeutics, Inc. stock is rated a SellThe current Avenue Therapeutics, Inc. [ATXI] share price is $0.35. The Score for ATXI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics, Inc. Stock Info
Market Cap:
1.1M
Price in USD:
0.35
Share Volume:
49
Avenue Therapeutics, Inc. 52-Week Range
52-Week High:
0.97
52-Week Low:
0.15
Sell
38
Avenue Therapeutics, Inc. (ATXI)
is a Sell
Avenue Therapeutics, Inc. Share Price Forecast
-
What is the Avenue Therapeutics, Inc. stock price today?The Avenue Therapeutics, Inc. stock price is 0.35 USD today.
-
Will ATXI stock go up or go down?Avenue Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Avenue Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics, Inc. is overvalued.
Is Avenue Therapeutics, Inc. Stock a Buy?
-
Avenue Therapeutics, Inc. share price is 0.35 while ATXI 8-day exponential moving average is 0.30, which is a Buy signal.
-
The stock price of ATXI is 0.35 while Avenue Therapeutics, Inc. 20-day EMA is 0.23, which makes it a Buy.
-
Avenue Therapeutics, Inc. 50-day exponential moving average is 0.13 while ATXI share price is 0.35, making it a Buy technically.
-
ATXI stock price is 0.35 and Avenue Therapeutics, Inc. 200-day simple moving average is 0.04, creating a Buy signal.
Technical Analysis of Avenue Therapeutics, Inc.
Should I short Avenue Therapeutics, Inc. stock?
-
ATXI Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Avenue Therapeutics, Inc. is a Buy
-
Avenue Therapeutics, Inc. Relative Strength Index (RSI) is 62.2, which suggest Avenue Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Avenue Therapeutics, Inc. is (0.21 - 0.31), which suggest Avenue Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Avenue Therapeutics, Inc. is (0.23 - 0.73), which suggest Avenue Therapeutics, Inc. is a Sell
* Avenue Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.